pharmacie et médicaments – Autorisation de mise sur le marché de médicaments CAR-T cells et bispécifiques

This written question concerns the process for authorising new types of advanced therapy medicinal products, specifically CAR-T cells and bispecific drugs. It seeks clarification on the regulatory framework governing their market approval. The question impacts patients, healthcare providers, and pharmaceutical companies involved in the development and use of these innovative treatments. It aims to ensure timely access to potentially life-saving therapies.